SERUM TOCILIZUMAB TROUGH CONCENTRATIONS ARE ASSOCIATED WITH CLINICAL DISEASE ACTIVITY INDEX SCORES IN ADULT RHEUMATOID ARTHRITIS PATIENTS

被引：0
|
作者：
Arad, U. [1 ,2 ]
Elkayam, O. [1 ,2 ]
机构：
[1] Tel Aviv Sourasky Med Ctr, Rheumatol, Tel Aviv, Israel
[2] Tel Aviv Univ, Fac Med, Tel Aviv, Israel
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2018年 / 77卷
关键词：
D O I：
10.1136/annrheumdis-2018-eular.5116
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OP0110
引用
收藏
页码：105 / 105
页数：1
相关论文
共 50 条
  • [31] Dose Reduction Of Tocilizumab In Rheumatoid Arthritis Patients With Low Disease Activity Is Feasible
    van Herwaarden, Noortje
    Herfkens-Hol, Susan
    van der Maas, Aatke
    van Den Bemt, Bart J. F.
    van Vollenhoven, Ronald F.
    Bijlsma, Johannes W. J.
    den Broeder, Alfons A.
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S992 - S992
  • [32] CLINICAL AND SEROLOGICAL RESPONSE TO TOCILIZUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Casu, C.
    Bruschi, E.
    Alpini, C.
    Marceglia, S.
    Giacomelli, L.
    Epis, O.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 880 - 880
  • [33] Patients' and clinicians' perspectives on the clinical utility of the Rheumatoid Arthritis Foot Disease Activity Index
    Hoque, A.
    Hendry, G. J.
    Steultjens, M. P.
    Dickson, D. M.
    [J]. SCOTTISH MEDICAL JOURNAL, 2022, 67 (01) : 48 - 48
  • [34] PATIENTS' AND CLINICIANS' PERSPECTIVES ON THE CLINICAL UTILITY OF THE RHEUMATOID ARTHRITIS FOOT DISEASE ACTIVITY INDEX
    Hoque, Anika
    [J]. RHEUMATOLOGY, 2022, 61 : I106 - I106
  • [35] Patients’ and clinicians’ perspectives on the clinical utility of the Rheumatoid Arthritis Foot Disease Activity Index
    Anika Hoque
    Martijn Steultjens
    Diane M. Dickson
    Gordon J. Hendry
    [J]. Rheumatology International, 2022, 42 : 1807 - 1817
  • [36] Patients' and clinicians' perspectives on the clinical utility of the Rheumatoid Arthritis Foot Disease Activity Index
    Hoque, Anika
    Steultjens, Martijn
    Dickson, Diane M.
    Hendry, Gordon J.
    [J]. RHEUMATOLOGY INTERNATIONAL, 2022, 42 (10) : 1807 - 1817
  • [37] The combined use of disease activity and infliximab serum trough concentrations for early prediction of (non-)response to infliximab in rheumatoid arthritis
    van den Bemt, Bart J. F.
    den Broeder, Alfons A.
    Wolbink, Gert-Jan
    van den Maas, Aatke
    Hekster, Yechiel A.
    van Riel, Piet L. C. M.
    Benraad, H. Bart
    van den Hoogen, Frank H. J.
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 76 (06) : 939 - 945
  • [38] Tocilizumab Effect on Serum Angiogenic Factors in Rheumatoid Arthritis Patients
    Elias, Muna
    Rahat, Michal Amit
    Feld, Joy
    Rosner, Itzhak
    Kaly, Lisa
    Lavi, Idit
    Gazitt, Tal
    Zisman, Devy
    [J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [39] Use of Clinical Disease Activity Index Score for Assessment of Disease Activity in Rheumatoid Arthritis Patients: An Indian Experience
    Singh, H.
    Kumar, H.
    Handa, R.
    Talapatra, P.
    Ray, S.
    Gupta, V.
    [J]. ARTHRITIS, 2011,
  • [40] The Utility of the Clinical Disease Activity Index for Tight Control of disease activity in South African Rheumatoid Arthritis patients
    Hodkinson, B.
    Monyai, N.
    Tikly, M.
    [J]. CLINICAL RHEUMATOLOGY, 2013, 32 : S132 - S132
12345